Non-Small Cell Lung Cancer, Version 1.2020 Featured Updates to the NCCN Guidelines
Non-Small Cell Lung Cancer, Version 1.2020 Featured Updates to the NCCN Guidelines
复制标题
DOI：
10.6004/jnccn.2019.0059
复制
发表时间：
2019-12-01
影响因子：
13.4
通讯作者：
Hughes, Miranda
中科院分区：
文献类型：
--
作者：
Ettinger, David S.;Wood, Douglas E.;Hughes, Miranda
NCCN非小细胞肺癌（NSCLC）指南涉及NSCLC管理的所有方面。这些NCCN指南见解专注于免疫治疗的最新更新。对于2020年的更新，所有的全身治疗方案都使用了新的偏好分层系统进行了分类;某些方案现在被推荐为“首选干预措施”，而其他方案则被归类为“其他推荐干预措施”或“在某些情况下有用”。"
The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates in immunotherapy. For the 2020 update, all of the systemic therapy regimens have been categorized using a new preference stratification system; certain regimens are now recommended as "preferred interventions," whereas others are categorized as either "other recommended interventions" or "useful under certain circumstances."